Swissquote Bank SA insider trades: Cytori Therapeutics (CYTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Swissquote Bank SA reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 11, 2018 | CYTX | ↓ Sell | 188,426 | $0.37 | $69K | Direct | Jan 11, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Swissquote Bank SA's insider trades
Swissquote Bank SA is an insider at Cytori Therapeutics (CYTX). Since Jan 11, 2018, it has reported no open-market purchases and 1 sale worth $69K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.